mRNA vaccines are vaccine platforms that deliver messenger RNA molecules encoding target antigens into cells, prompting those cells to produce the antigen and trigger an immune response without introducing live or inactivated pathogens. Since their breakthrough authorization for COVID-19 prevention in 2020, mRNA technology has expanded rapidly into oncology, where therapeutic cancer vaccines are now advancing through clinical trials for melanoma, pancreatic cancer, and other malignancies.
Understanding the advantages and …

The Impact Factor for Trends in Molecular Medicine stands at 18.1 for 2026, placing the journal at rank 8 out of 328 publications in the molecular biology category and securing a Q1 (first quartile) designation. This metric quantifies how frequently articles published in the journal are cited by other researchers, calculated by dividing the number of citations in the current year by the total number of citable articles published in the preceding two years.
For molecular biologists, clinicians, and research administrators evaluating publication venues or assessing scholarly contributions, understanding these numbers matters beyond …

Artificial intelligence and data science have fundamentally transformed molecular biology research by enabling scientists to extract meaningful patterns from massive genomic datasets, predict protein structures with unprecedented accuracy, and accelerate drug discovery timelines from years to months. These computational disciplines now serve as essential tools in modern laboratories, where researchers apply machine learning algorithms to interpret complex biological systems, automate experimental workflows, and identify therapeutic targets that would remain hidden in traditional analysis approaches.
The integration of AI-driven …

Impact factor trends in cell biology refer to the shifting patterns in journal citation metrics that measure how frequently articles from specific cell biology publications are cited within the scientific literature. These metrics, primarily calculated as the average number of citations per article over a two-year period, have become increasingly complex as new alternatives and complementary measures emerge to evaluate research influence.
The landscape of academic publishing in cell biology has transformed substantially. Traditional impact factors, once the dominant measure of journal prestige, now compete with article-level metrics…

An RNA cancer vaccine is a therapeutic platform that trains the immune system to recognize and attack cancer cells by delivering messenger RNA encoding tumor-associated antigens, prompting the patient’s own cells to produce these proteins and trigger a targeted immune response.
This molecular approach represents a fundamental shift in oncology. Unlike chemotherapy or radiation, which directly kill malignant cells, RNA vaccines harness the body’s immune surveillance to selectively eliminate tumor tissue while sparing healthy cells. The technology emerged from decades of immunotherapy research but gained unprecedented …